Loading
AB
Asterias Biotherapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Mulroy Michael H., was filed 29 Aug 2018.
Asterias Biotherapeutics, Inc.: what insiders have been doing
Asterias Biotherapeutics, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Asterias Biotherapeutics, Inc. has had no insider filing for more than a year; the last one goes back to 12 March 2019.
The full history, which starts in 2016, counts 23 purchases against 13 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
83
Thresholds
n/a
Buy Volume
€4M
23 ops. · all time
Sell Volume
€232,472
13 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Gross profit3.5M
Net income-25.3M
Last declaration on 12 March 2019
Declarations83 total
5,292,156 sharesSeries A Common StockSEC:0000919574-19-002302:0
00Series A Common StockSEC:0000919574-19-002302:1
156,452 shares0Common StockSEC:0001140361-19-004433:0
252,606 shares0Common StockSEC:0001140361-19-004431:0
145,263 shares0Common StockSEC:0001140361-19-004430:0
44,471 shares@ US$0.9575.4% of flowCommon StockSEC:0001140361-19-004430:1
48,826 shares@ US$0.9577.1% of flowCommon StockSEC:0001140361-19-004433:1
76,588 shares@ US$0.9571.7% of flowCommon StockSEC:0001140361-19-004431:1
20,440 shares@ US$0.6812.6% of flowCommon StockSEC:0001140361-19-000390:0
20,440 shares@ US$0.6813.3% of flowCommon StockSEC:0001140361-19-000392:0
3,141 shares@ US$1.592.8% of flowCommon StockSEC:0001140361-18-037213:0
Canonical exit: 25 Nov 2018 (T+90)
2,950 shares@ US$1.692.7% of flowCommon StockSEC:0001140361-18-033875:0
Canonical exit: 23 Oct 2018 (T+90)
3,067 shares@ US$1.632.8% of flowCommon StockSEC:0001140361-18-030023:0
Canonical exit: 23 Sept 2018 (T+90)
3,153 shares@ US$1.592.7% of flowCommon StockSEC:0001140361-18-026566:0
Canonical exit: 23 Aug 2018 (T+90)
3,752 shares@ US$1.332.6% of flowCommon StockSEC:0001140361-18-020186:0
Canonical exit: 24 Jul 2018 (T+90)
6,483 shares@ US$1.453.4% of flowCommon StockSEC:0001140361-18-016243:0
6,483 shares@ US$1.458.4% of flowCommon StockSEC:0001140361-18-016241:0
2,839 shares@ US$1.762.5% of flowCommon StockSEC:0001140361-18-015535:0
Canonical exit: 24 Jun 2018 (T+90)
28,358 shares@ US$1.9528.1% of flowCommon StockSEC:0001140361-18-014136:1
74,000 shares0Common StockSEC:0001140361-18-014134:1
68,708 shares0Common StockSEC:0001140361-18-014132:1
94,872 shares0Common StockSEC:0001140361-18-014136:0
50,000 shares0Common Stock (restricted stock units)SEC:0001140361-18-014134:0
50,000 shares0Common Stock (restricted stock units)SEC:0001140361-18-014132:0
22,686 shares@ US$1.9516.0% of flowCommon StockSEC:0001140361-18-014134:2
25 of 83 declarations
About Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. is a biopharmaceutical company focused on developing cell and gene therapies for serious diseases. It is listed on NASDAQ under the symbol Asterias.
